Clinical Trials Browser

Phase 2/3 × Active not recruiting × venetoclax × Clear all

NCT03984448 2026-03-18

Testing the Addition of a New Anti-cancer Drug, Venetoclax, to Usual Chemotherapy for High Grade B-cell Lymphomas

Phase 2/3 Active not recruiting

Lymphoma, Large B-Cell, Diffuse

NCT05356169 2025-05-30

Intensive Therapy Combined With Venetoclax for Adult Acute Myeloid Leukemia

Phase 2/3 Active not recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute